Search

Your search keyword '"Hooda, Amit"' showing total 50 results
Start Over Author "Hooda, Amit" Search Limiters Academic (Peer-Reviewed) Journals
50 results on '"Hooda, Amit"'

7. Impact of Clinical Presentation on Outcomes After Rotational Atherectomy in Patients Who Underwent Percutaneous Coronary Intervention

Author

Farooq, Ali, Koshy, Anoop N., Giustino, Gennaro, Sartori, Samantha, Snyder, Clayton, Hooda, Amit, Farhan, Serdar, Kyaw, Htoo, Khan, Mahin, Vinayak, Manish, Arora, Ayush, Dhulipala, Vishal, Suleman, Javed, Krishnamoorthy, Parasuram, Khera, Sahil, Sweeny, Joseph, Mehran, Roxana, Kini, Annapoorna S., and Sharma, Samin K.

Published
2023
Full Text
View/download PDF

10. Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft Surgery.

Author

Koshy, Anoop N., Stone, Gregg W., Sartori, Samantha, Dhulipala, Vishal, Giustino, Gennaro, Spirito, Alessandro, Farhan, Serdar, Smith, Kenneth F., Yihan Feng, Vinayak, Manish, Salehi, Negar, Tanner, Richard, Hooda, Amit, Krishnamoorthy, Parasuram, Sweeny, Joseph M., Khera, Sahil, Dangas, George, Filsoufi, Farzan, Mehran, Roxana, and Kini, Annapoorna S.

Published
2024
Full Text
View/download PDF

11. Transcatheter Aortic Valve Replacement: Current Status and Future Indications.

Author

Vinayak, Manish, Leone, Pier Pasquale, Tanner, Richard, Dhulipala, Vishal, Camaj, Anton, Makhija, Rakhee Rajendra Kumar, Hooda, Amit, Kini, Annapoorna S., Sharma, Samin K., and Khera, Sahil

Subjects
HEART valve prosthesis implantation, AORTIC stenosis, LONGEVITY
Abstract

In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the management of aortic stenosis and has become the standard of care regardless of surgical risk levels. Advances in transcatheter valve design across newer generations, improved imaging, greater operator expertise, and technical enhancements have collectively contributed to increased safety and a decline in procedural complications over this timeframe. The application of TAVR has progressively expanded to include younger patients with lower risks, who have longer life expectancies. This article offers an up-to-date review of the latest innovations in transcatheter delivery systems, devices, and its possible future indications. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. A Narrative Review on Periprocedural Stroke and Transcatheter Aortic Valve Replacement: Achilles’ Heel.

Author

Kodan, Parul, Khurana, Sakshi, Gulati, Amit, and Hooda, Amit

Subjects
STROKE treatment, STROKE prevention, PREVENTION of surgical complications, STROKE diagnosis, PERIOPERATIVE care, FIBRINOLYTIC agents, CEREBRAL embolism & thrombosis, HEART valve prosthesis implantation, STROKE, COMBINATION drug therapy, ORAL drug administration, AORTIC stenosis, THERAPEUTIC embolization, ANTICOAGULANTS, SEVERITY of illness index, INFECTIVE endocarditis, PLATELET aggregation inhibitors, PROSTHETIC heart valves, EARLY diagnosis, EARLY medical intervention, DISEASE risk factors
Abstract

Transcatheter aortic valve replacement (TAVR) has become the treatment option for symptomatic severe aortic stenosis patients across all risk profiles. Despite remarkable advancements in technology and operator experience, the occurrence of periprocedural stroke remains a significant concern, predominantly attributed to thromboembolic events in the immediate postprocedural period. To optimize patient outcomes, various strategies have been developed to minimize the risk of stroke, encompassing comprehensive preprocedural planning, effective management of comorbidities, utilization of cerebral embolic protection devices, and tailored medical therapy. This comprehensive review summarizes the currently available strategies for mitigating periprocedural stroke post‑TAVR and provides insights into future directions. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

16. Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention.

Author

Koshy, Anoop N., Giustino, Gennaro, Sartori, Samantha, Kyaw, Htoo, Yadav, Mayank, Zhang, Zhongjie, Hooda, Amit, Farooq, Ali, Krishnamoorthy, Parasuram, Sweeny, Joseph M., Khera, Sahil, Serrao, Gregory W., Sharma, Raman, Suleman, Javed, Dangas, George, Kini, Annapoorna S., Mehran, Roxana, and Sharma, Samin K.

Abstract

Potent P2Y 12 agents such as ticagrelor and prasugrel are increasingly utilized across the clinical spectrum of patients undergoing percutaneous coronary intervention (PCI). There is a paucity of data supporting their use in a patient population inclusive of both acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) patients. The authors compared the efficacy and safety of ticagrelor and prasugrel in a real-world contemporary PCI cohort. Consecutive patients undergoing PCI between 2014 and 2019 discharged on either prasugrel or ticagrelor were included from the prospectively collected institutional PCI registry. Primary endpoint was the composite of death and myocardial infarction (MI), with secondary outcomes including rates of bleeding, stroke, and target vessel revascularization at 1 year. Overall, 3,858 patients were included in the study (ticagrelor: n = 2,771; prasugrel: n = 1,087), and a majority (48.4%) underwent PCI in the context of CCS. Patients prescribed ticagrelor were more likely to be female, have a history of cerebrovascular disease, and have ACS presentation, while those receiving prasugrel were more likely to be White with a higher prevalence of prior revascularization. No difference in the risk of death or MI was noted across the groups (ticagrelor vs prasugrel: 3.3% vs 3.1%; HR: 0.88; 95% CI: 0.54-1.43; P = 0.59). Rates of target vessel revascularization were significantly lower in the ticagrelor cohort (9.3% vs 14.0%; adjusted HR: 0.71; 95% CI: 0.55-0.91; P = 0.007) with no differences in stroke or bleeding. The results were consistent in patients with CCS (HR: 0.84; 95% CI: 0.46-1.54) and ACS (HR: 1.18; 95% CI: 0.46-1.54), without evidence of interaction (P = 0.37), and confirmed across multivariable adjustment and propensity score stratification analysis. In this contemporary patient population undergoing PCI, prasugrel and ticagrelor were associated with similar 1-year efficacy and safety. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

18. TAVR - From inoperable to younger, lower-risk patients: A slippery slope?

Author

Unbehaun, Axel, Abdullah, Mohamed, Hooda, Amit, Gedela, Maheedhar, Kempfert, Joerg, Klein, Christoph, and Tang, Gilbert H.L.

Abstract

Despite current valve guidelines recommending both transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively) in patients with symptomatic severe aortic stenosis (AS), TAVR has recently become the preferred treatment over SAVR, driven by its minimal invasiveness, faster recovery and earlier improvement in quality of life. However, several limitations and unresolved issues remain with TAVR, including stroke, conduction system disorder, durability, bicuspid anatomy, coronary reaccess and lifetime management with aortic valve reintervention. Our review aims to highlight the above issues and discuss them in depth, to demonstrate the complementary role of TAVR and SAVR in the treatment of AS. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

19. Outcomes and feasibility of redo‐TAVR after Sapien 3 Ultra TAVR in extremely‐undersized versus nominally‐sized annuli.

Author

Tang, Gilbert H. L., Hooda, Amit, Zaid, Syed, Chuang, Ming‐Yu, Khera, Sahil, Krishnamoorthy, Parasuram, Lerakis, Stamatios, Anastasius, Malcolm, Ahmad, Hasan A., Goldberg, Joshua B., Akodad, Mariama, Wood, David A., Leipsic, Jonathon A., Blanke, Philipp, Dangas, George D., Sharma, Samin K., Kini, Annapoorna S., Webb, John G., and Sathananthan, Janarthanan

Published
2022
Full Text
View/download PDF

22. Intricate interplay between Covid‐19 and cardiovascular diseases.

Author

Keri, Vishakh C., Hooda, Amit, Kodan, Parul, R L, Brunda, Jorwal, Pankaj, and Wig, Naveet

Abstract

Summary: Covid‐19 disease can involve any organ system leading to myriad manifestations and complications. Cardiovascular manifestations are being increasingly recognised with the improved understanding of the disease. Acute coronary syndrome, myocarditis, arrhythmias, cardiomyopathy; heart failure and thromboembolic disease have all been described. The elderly and those with prior cardiac diseases are at an increased risk of mortality. Overlapping symptomatology, ability of drugs to cause QTc interval (start of Q wave to the end of T wave) prolongation on electrocardiogram and arrhythmias, potential drug interactions, the need to recognise patients requiring urgent definitive management and provide necessary bedside interventions without increasing the risk of nosocomial spread have made the management challenging. In the background of a pandemic, non‐Covid‐19 cardiac patients are affected by delayed treatment and nosocomial exposure. Triaging using telemedicine and artificial intelligence along with utilization of bedside rapid diagnostic tests to detect Covid‐19 could prove helpful in this aspect. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

24. Protein S deficiency: Recurrent ischemic stroke in young

Author

Hooda, Amit, Khandelwal, P., and Saxena, Puneet

Subjects
Stroke (Disease) -- Complications and side effects, CT imaging -- Usage -- Health aspects, Protein S deficiency -- Risk factors -- Diagnosis -- Care and treatment -- Patient outcomes -- Case studies, Health, Diagnosis, Care and treatment, Usage, Complications and side effects, Case studies, Risk factors, Patient outcomes, Health aspects
Abstract

Byline: Amit. Hooda, P. Khandelwal, Puneet. Saxena Stroke in young poses a major health problem. Thrombophilic factors have been implicated in 4-8% of the young strokes worldwide. Protein S deficiency [...]

Published
2009

25. TCT-543 Clinical and Procedural Risk Predictors of Acute Kidney Injury Following Transcatheter Aortic Valve Replacement: Findings From a Real-World Registry.

Author

Hooda, Amit, Yadav, Mayank, Bagga, Shiv, Koshy, Anoop, Dwivedi, Prashant, Gedela, Maheedhar, Sartori, Samantha, Snyder, Clayton, Thapi, Roja, Bande, Prathyusha, Vijay, Pooja, Kyaw, Htoo, Ranadive, Isha, Kumar, Kartik, Farhan, Serdar, Goel, Sunny, Krishnamoorthy, Parasuram, Dangas, George, Mehran, Roxana, and Kini, Annapoorna

Subjects
*HEART valve prosthesis implantation, *ACUTE kidney failure
Published
2022
Full Text
View/download PDF

26. TCT-390 Clinical and Echocardiographic Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Nominally Sized Annuli.

Author

Hooda, Amit, Chuang, Anthony, Zaid, Syed, Krishnamoorthy, Parasuram, Khera, Sahil, Lerakis, Stamatios, Ahmad, Hasan, Goldberg, Joshua, Wood, David, Leipsic, Jonathon, Blanke, Philipp, Dangas, George, Sharma, Samin, Kini, Annapoorna, Webb, John, Sathananthan, Janarthanan, and Tang, Gilbert

Subjects
*TREATMENT effectiveness
Published
2021
Full Text
View/download PDF

27. Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard CRT-D device.

Author

Chase, David, Kumar, Vipin, and Hooda, Amit

Abstract

Abstract: In patients undergoing cardiac resynchronization therapy with defibrillator (CRT-D) implantation for left ventricular systolic dysfunction (LVSD) accompanied by permanent atrial fibrillation (AF), generally, the unused atrial port is plugged at device implantation. We describe an alternative use for the atrial-port in this case report. A 43year old gentleman with LVSD due to left ventricular non-compaction (LVNC) and AF of unknown duration underwent a CRT-D implantation after optimization of cardiac failure treatment. The atrial-port which would otherwise have been plugged was connected to a high right ventricular septal (RVS) pacing-lead and the shock-lead was positioned at the right ventricular apex (RVA). This approach permitted modified cardiac resynchronization in a high RVS to left ventricular (LV) and RVA pacing sequence using the high RVS and LV pacing combined with a shock vector including the RV apex. A standard CRT-D device with a minimum programmable A–V delay of 30ms (technically RVS to LV delay in the ‘DDD’ pacing mode) was used. The device was programmed to a ‘DDD’ pacing mode (sequential multi-site ventricular pacing with some programmability). The mode switch operation was programmed ‘OFF’ since atrial sensing is unavailable. Device-delivered shocks did not cardiovert the patient back to sinus rhythm suggesting that the AF was permanent (no prior cardioversion attempts were made on the presumption that the chances of maintaining sinus rhythm, given the underlying cardiac condition, were low). Subsequently, the patient required radio-frequency ablation of the atrio-ventricular node for conducted AF. Symptomatic, echocardiographic and radiological improvement preceded atrio-ventricular node ablation. Conclusion: Amongst AF patients with permanent AF undergoing CRT-D implantation, those patients who are likely to have the CRT-D device atrial-ports plugged could benefit from having both the options of (i) a RVA shock vector as well as (ii) a high RVS-pacing feasible, by utilizing the atrial-port of a conventional CRTD device for a RVS pacing lead, should a RVA shock-lead position be preferred. New device programming algorithms will be necessary to make patient-customized programming in this lead configuration flexible, more useful clinically and easy. [Copyright &y& Elsevier]

Published
2013
Full Text
View/download PDF

30. Doctor and Healing Touch.

Author

KODAN, PARUL, HOODA, AMIT, and KODAN, PALLAVI

Subjects
*THERAPEUTIC touch, *MEDICINE, *TRADITIONAL medicine, *HYPERESTHESIA, *HISTORY of medicine
Abstract

The article presents the author's views on the aspects of healing touch of medical profession and the clinical experiences in this rigorous, perplexing, enigmatic world of medicine. Topics further discusses includes the evidence of health marketing, art of clinical practice and needs and limitations of the medicos.

Published
2014
Full Text
View/download PDF

32. SHOULD ADDITIONAL VESSELS BE TREATED DURING LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM A LARGE PROSPECTIVE REGISTRY.

Author

Power, David, Roumeliotis, Anastasios, Camaj, Anton, Sartori, Samantha, Smith, Kenneth, Nicolas, Johny, Tanner, Richard, Makhija, Rakhee R, Leone, Pier Pasquale, Yasumura, Keisuke, Vinayak, Manish, Hooda, Amit, Krishnamoorthy, Parasuram Melarcode, Farhan, Serdar, Sweeny, Joseph Michael, Dangas, George D., Mehran, Roxana, Kini, Annapoorna Subhash, and Sharma, Samin K.

Subjects
*PERCUTANEOUS coronary intervention
Published
2024
Full Text
View/download PDF

33. PROVISIONAL VS TWO-STENT STRATEGY IN THE TREATMENT OF TRUE BIFURCATION CORONARY LESIONS: OUTCOMES STRATIFIED BY LESION COMPLEXITY.

Author

Minatoguchi, Shingo, Vengrenyuk, Yuliya, Yasumura, Keisuke, sartori, samantha, Koshy, Anoop Ninan, Sharma, Raman, Krishnamoorthy, Parasuram Melarcode, Suleman, Javed, Sweeny, Joseph Michael, Hooda, Amit, Kapur, Vishal, Sharma, Samin K., and Kini, Annapoorna Subhash

Subjects
*CORONARY disease, *MUCOCUTANEOUS lymph node syndrome
Published
2024
Full Text
View/download PDF

34. A NOVEL RISK SCORE TO PREDICT ONE-YEAR RISK OF MACE IN PATIENTS UNDERGOING CORONARY TRUE BIFURCATION INTERVENTION.

Author

Minatoguchi, Shingo, Vengrenyuk, Yuliya, Yasumura, Keisuke, sartori, samantha, Koshy, Anoop Ninan, Sharma, Raman, Krishnamoorthy, Parasuram Melarcode, Suleman, Javed, Sweeny, Joseph Michael, Hooda, Amit, Kapur, Vishal, Sharma, Samin K., and Kini, Annapoorna Subhash

Subjects
*DISEASE risk factors, *MAJOR adverse cardiovascular events, *FORECASTING
Published
2024
Full Text
View/download PDF

35. CLINICAL IMPACT OF PROCEDURAL COMPLEXITY AND HIGH BLEEDING RISK STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.

Author

Mehran, Roxana, Oliva, Angelo, Sartori, Samantha, Cao, Davide, Vogel, Birgit, Bay, Benjamin, Kim, Chan Joon, Feng, Yihan, Thapi, Roja, Nicolas, Johny, Hooda, Amit, Sharma, Raman, Sweeny, Joseph Michael, Stefanini, Giulio G., Dangas, George D., Kini, Annapoorna Subhash, and Sharma, Samin K.

Subjects
*PERCUTANEOUS coronary intervention, *CHRONIC kidney failure, *CHRONICALLY ill, *HEMORRHAGE
Published
2024
Full Text
View/download PDF

36. IMPACT OF DIABETES MELLITUS ON 1-YEAR OUTCOMES OF BIODEGRADABLE VERSUS DURABLE POLYMER DRUG ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOLLOWING ROTATIONAL ATHERECTOMY: RESULTS FROM LARGE PROSPECTIVE REGISTRY.

Author

Makhija, Rakhee R, Siano, Matthew, Patel, Neelkumar, Farhan, Serdar, Power, David, Sartori, Samantha, Feng, Yihan, Cheng, Wen, Camaj, Anton, Dhulipala, Vishal, Yasumura, Keisuke, Thapi, Roja, Vijay, Pooja, Gurung, Nikito, Vinayak, Manish, Hooda, Amit, Krishnamoorthy, Parasuram Melarcode, Sweeny, Joseph Michael, Dangas, George D., and Mehran, Roxana

Subjects
*DRUG-eluting stents, *PERCUTANEOUS coronary intervention, *ATHERECTOMY, *DIABETES, *POLYMERS, *DRUGS
Published
2024
Full Text
View/download PDF

37. IMPACT OF LEFT VENTRICULAR EJECTION FRACTION ON 1-YEAR OUTCOMES IN PATIENTS WITH END-STAGE RENAL DISEASE FOLLOWING PERCUTANEOUS CORONARY INTERVENTION.

Author

Pitaro, Nicholas, Nicolas, Johny, Sartori, Samantha, Feng, Yihan, Gurung, Nikito, Sweeny, Joseph Michael, Kapur, Vishal, Suleman, Javed, Hooda, Amit, Sharma, Raman, Kini, Annapoorna Subhash, Dangas, George D., Sharma, Samin K., and Mehran, Roxana

Subjects
*PERCUTANEOUS coronary intervention, *CHRONIC kidney failure, *VENTRICULAR ejection fraction, *TREATMENT effectiveness, *HEART failure, *MYOCARDIAL infarction
Published
2024
Full Text
View/download PDF

38. IMPACT OF POLYVASCULAR DISEASE ON MORTALITY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE.

Author

Bay, Benjamin, Roumeliotis, Anastasios, Sartori, Samantha, Power, David, Vogel, Birgit, Smith, Kenneth, Thapi, Roja, Nicolas, Johny, Kim, Chan Joon, Oliva, Angelo, Cao, Davide, Hooda, Amit, Sharma, Raman, Sweeny, Joseph Michael, Krishnan, Prakash, Dangas, George D., Kini, Annapoorna Subhash, Sharma, Samin K., and Mehran, Roxana

Subjects
*PERCUTANEOUS coronary intervention, *CORONARY artery disease, *MORTALITY, *MYOCARDIAL infarction
Published
2024
Full Text
View/download PDF

39. OUTCOMES OF PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION STRATIFIED BY TREATMENT WITH OR WITHOUT GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONISTS.

Author

Penta, Bhavanadhar, Farhan, Serdar, Sartori, Samantha, Dhulipala, Vishal, Vijay, Pooja, Gurung, Nikito, Feng, Yihan, Vinayak, Manish, Hooda, Amit, Sharma, Raman, Krishnamoorthy, Parasuram Melarcode, Kapur, Vishal, Sweeny, Joseph Michael, Mehran, Roxana, Kini, Annapoorna Subhash, and Sharma, Samin K.

Subjects
*PERCUTANEOUS coronary intervention, *PEPTIDE receptors, *GLUCAGON-like peptide-1 agonists, *PEOPLE with diabetes, *DIABETES, *GLUCAGON, *PRASUGREL
Published
2024
Full Text
View/download PDF

40. INFLAMMATION AND CONTRAST ASSOCIATED ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.

Author

Nicolas, Johny, Dangas, George D., Sartori, Samantha, Feng, Yihan, Vogel, Birgit, Camaj, Anton, Beerkens, Frans, Power, David, Roumeliotis, Anastasios D., Oliva, Angelo, Bay, Benjamin, Fisher, Rebecca, Byrne, Katie Kenny, Sharma, Raman, Sweeny, Joseph Michael, Hooda, Amit, Kapur, Vishal, Serrao, Gregory, Kini, Annapoorna Subhash, and Sharma, Samin K.

Subjects
*PERCUTANEOUS coronary intervention, *ACUTE kidney failure, *INFLAMMATION
Published
2024
Full Text
View/download PDF

43. TCT-749 Predictors of Suboptimal Stent Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis: Insights From Intravascular Imaging.

Author

Yasumura, Keisuke, Vengrenyuk, Yuliya, Minatoguchi, Shingo, Koshy, Anoop, Tanner, Richard, Dhulipala, Vishal, Ranadive, Isha, Hooda, Amit, Krishnamoorthy, Parasuram, Sharma, Raman, Suleman, Javed, Kapur, Vishal, Sharma, Samin, and Kini, Annapoorna

Subjects
*CORONARY restenosis, *LITHOTRIPSY
Published
2023
Full Text
View/download PDF

46. TICAGRELOR OR PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC CORONARY SYNDROMES: RESULTS FROM A REAL-WORLD REGISTRY.

Author

Koshy, Anoop Ninan, Giustino, Gennaro, Sartori, Samantha, Hooda, Amit, Feng, Yihan, Snyder, Clayton, Smith, Kenneth, Kumar, Kartik, Chen, Shiwei, Krishnamoorthy, Parasuram Melarcode, Dhulipala, Vishal, Sweeny, Joseph M., Khera, Sahil, Serrao, Gregory, Sharma, Raman, Dangas, George D., Kini, Annapoorna Subhash, Mehran, Roxana, and Sharma, Samin K.

Subjects
*PERCUTANEOUS coronary intervention, *TICAGRELOR, *PRASUGREL, *CLOPIDOGREL, *SYNDROMES
Published
2023
Full Text
View/download PDF

47. PROCEDURAL SUCCESS AND CLINICAL OUTCOMES IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION OF ANOMALOUS CORONARY ARTERIES.

Author

Koshy, Anoop Ninan, Kumar, Kartik, Giustino, Gennaro, Sartori, Samantha, Iruvanti, Suvruta S., Dhulipala, Vishal, Fisher, Rebecca, Feng, Yihan, Hooda, Amit, Chen, Shiwei, Mehran, Roxana, Kini, Annapoorna Subhash, and Sharma, Samin K.

Subjects
*PERCUTANEOUS coronary intervention, *CORONARY arteries, *TREATMENT effectiveness, *SUCCESS
Published
2023
Full Text
View/download PDF

48. SYNERGISTIC USE OF ROTATIONAL ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY AS A CALCIUM MODIFICATION STRATEGY IN HEAVILY CALCIFIED, LARGE CALIBER CORONARY ARTERIES.

Author

Dhulipala, Vishal, Dwivedi, Prashant, Koshy, Anoop Ninan, Kumar, Kartik, Yasumura, Keisuke, Hooda, Amit, Salehi, Negar, Vinayak, Manish, Sharma, Raman, Dangas, George D., Kini, Annapoorna Subhash, and Sharma, Samin K.

Subjects
*ATHERECTOMY, *CORONARY arteries, *LITHOTRIPSY, *CALCIUM
Published
2023
Full Text
View/download PDF

50. TCT-27 Ticagrelor Versus Prasugrel in an All-Comer Patient Cohort Undergoing Percutaneous Coronary Intervention.

Author

Koshy, Anoop, Giustino, Gennaro, Sartori, Samantha, Kyaw, Htoo, Yadav, Mayank, Zhang, Zhongjie, Hooda, Amit, Farooq, Ali, Krishnamoorthy, Parasuram, Sweeny, Joseph, Sharma, Raman, Suleman, Javed, Dangas, George, Kini, Annapoorna, Mehran, Roxana, and Sharma, Samin

Subjects
*PERCUTANEOUS coronary intervention, *TICAGRELOR, *PRASUGREL
Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results